THE BALANCE Study: Treatment of Hyponatraemia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

Trial Profile

THE BALANCE Study: Treatment of Hyponatraemia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Lixivaptan (Primary)
  • Indications Hyponatraemia
  • Focus Registrational; Therapeutic Use
  • Acronyms BALANCE
  • Sponsors Cardiokine
  • Most Recent Events

    • 09 Aug 2014 New trial record
    • 24 Nov 2010
    • 24 Mar 2010
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top